| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-553
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985 |
| filingDate |
2019-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2022-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2022512871-A |
| titleOfInvention |
Novel 6,7-dihydro-4H-pyrazolo [1,5-A] pyrazine indole-2-carboxamide active against hepatitis B virus (HBV) |
| abstract |
The present invention generally relates to novel antiviral agents. Specifically, the invention is a compound capable of inhibiting a protein encoded by hepatitis B virus (HBV) or interfering with the function of the HBV replication cycle, a composition comprising such compound, a method of inhibiting HBV virus replication, HBV. It relates to a method for treating or preventing an infectious disease, as well as a method for producing the compound and an intermediate for producing the compound. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2022506337-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2022512870-A |
| priorityDate |
2018-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |